Bansal, N.; Sachdeva, N.; Bhurani, D.; Agarwal, N.; Ahmed, R.; Mehta, P.; Halder, R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS 2023, 13, 221-228. https://doi.org/10.18683/germs.2023.1388

AMA Style

Bansal N, Sachdeva N, Bhurani D, Agarwal N, Ahmed R, Mehta P, Halder R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS. 2023; 13(3):221-228. https://doi.org/10.18683/germs.2023.1388

Chicago/Turabian Style

Bansal, Nitin, Neelam Sachdeva, Dinesh Bhurani, Narendra Agarwal, Rayaz Ahmed, Pallavi Mehta, and Rohan Halder. 2023. "Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting" GERMS 13, no. 3: 221-228. https://doi.org/10.18683/germs.2023.1388

APA Style

Bansal, N., Sachdeva, N., Bhurani, D., Agarwal, N., Ahmed, R., Mehta, P., & Halder, R. (2023). Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS, 13(3), 221-228. https://doi.org/10.18683/germs.2023.1388

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI